NXGLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGLW

NEXGEL, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026

$5.80+0.21 (+3.76%)

Close on Oct 19, 2026

Market cap: $52.28M
P/E (TTM): –
Dividend yield: –

NEXGEL, INC. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31
Revenue	11	8.69	4.09	2.05	1.55	0.67	0.72	2.21
Cost of Revenue	6.91	5.94	3.72	1.79	1.54	0.97	0.85	1.70
Gross Profit	4.51	2.75	0.37	0.26	0.01	-0.29	-0.14	0.51
Research & Development	0.00	0.08	0.10	0.37	0.03	–	–	–
Selling, General & Admin	7.86	6.22	3.75	3.24	2.55	1.97	1.79	2.40
Operating Expenses	7.86	6.30	3.85	3.60	2.58	1.97	1.79	2.40
Operating Income	-3.35	-3.55	-3.48	-3.35	-2.57	-2.26	-1.92	-1.89
Interest Expense	0.03	0.08	0.02	1.34	–	–	–	–
Other Non-Operating Income	0.46	0.09	0.29	-1.40	-1.74	0.00	0.00	–
Asset Impairment Charges	–	0	0	0	0	–	–	–
Pretax Income	-2.89	-3.46	-3.19	-4.75	–	–	–	–
Income Tax Expense	–	–	–	0	0	0	0	–
Net Income incl. Noncontrolling Interests	-2.89	-3.46	-3.19	-4.75	-4.31	-2.26	-1.92	-1.89
Minority Interest in Earnings	0.11	-0.18	-0.03	–	–	–	–	–
Net Income	-3.00	-3.28	-3.16	-4.75	-4.31	-2.26	-1.92	-1.89
EPS (Basic)(per share)	-0.38	-0.50	-0.56	-0.85	-1.45	-1.05	-4.90	-13.30
EPS (Diluted)(per share)	-0.38	-0.50	-0.56	-0.85	-1.45	-1.05	-4.90	-13.30
Shares Outstanding (Basic, Weighted)(shares)	7.85	6.51	5.67	5.57	2.98	2.25	0.39	0.14
Shares Outstanding (Diluted, Weighted)(shares)	7.85	6.51	5.67	5.57	2.98	2.25	0.39	0.14
EBITDA	-2.90	-3.12	-3.25	-3.24	-2.46	-2.21	-1.86	-1.57

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 35.1%
Operating margin: -44.8%
Net margin: -51.3%
Return on equity, FY2025: -58.7%

Financial strength

Current ratio: 0.43
Debt to equity: 0.09
Debt to assets: 1.7%
Cash to current liabilities: 3.4%

Valuation

P/E ratio: –
Price to sales: 4.33
Price to book: 10.56
Dividend yield: –